Quarterly ResultApr 13, 2026, 01:16 PM
Lexaria Bioscience Cash Jumps to $5.13M in Q2 2026
AI Summary
Lexaria Bioscience Corp. reported a substantial increase in its cash position, reaching $5.13 million for the quarter ended February 28, 2026, up from $1.80 million as of August 31, 2025. This growth contributed to a rise in total current assets to $5.77 million and total assets to $6.49 million, indicating improved liquidity.
Key Highlights
- Cash increased to $5.13 million as of Feb 28, 2026.
- Cash was $1.80 million as of Aug 31, 2025.
- Total Current Assets rose to $5.77 million.
- Total Assets reached $6.49 million.